Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Medical Developments International Ltd

MVP.AX ✓ COMPLIANTFree checks used up today ☆ Track — members

ASX · Healthcare · Pharmaceuticals ·

Australia Micro Cap Analyst: BUY

Last Close

$0.34

▼ -2.02%

Market Cap $38.72M · Vol 13.75K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: 170.05

Market Cap

$38.72M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

-140.33%

YoY

RSI (14)

59.26

Momentum

Beta

2.36

vs Market

52W High

$0.54

29.57% below

52W Low

$0.26

39.27% above

Volume

13.75K

Avg 185.61K

P/B

N/A

Price-to-book

ROE

1.13%

Return on equity

Free Float

76.08%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Medical Developments International Ltd (MVP.AX) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MVP.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-4.90%

+5.43%

+27.63%

YTD

-12.61%

-28.15%

-43.56%

-87.84%

Financials & Valuation

TTM · Annual

Total Revenue	N/A
Net Income	N/A
Revenue Growth (YoY)	+10.11%
Gross Margin	65.75%
Operating Margin	2.48%
Net Profit Margin	N/A
ROE	1.13%
ROA · ROIC	N/A · N/A

P/E Ratio	N/A
Forward P/E (FY1)	170.05
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	-140.33%
Outstanding Shares	112.66M

Technical Indicators

50-Day SMA	$0.33
200-Day SMA	$0.32
RSI (14)	59.26
Beta	2.36
52-Week High	$0.54
52-Week Low	$0.26

Volume Today	13.75K
Avg Daily Volume (30D)	185.61K
Relative Volume	0.07x
Volatility (10D)	45.86
Volatility (30D)	61.81
Free Float	76.08%

Analyst Consensus

BUY

Current Price $0.34

Mean Target $0.70

52W Low$0.26 52W High$0.54

Current

Target

$0.26 $0.54

Current Analyst target

+102.42% upside potential · 1 analysts

Identifiers

ExchangeASX

FIGIBBG001SFMT05

ISINAU000000MVP2

CountryAustralia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateFeb 17, 2027

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Company +1.28% JNJ Johnson & Johnson +1.10% ABBV AbbVie Inc. +0.58% NVS Novartis AG +1.60% NOVN.S Novartis AG +1.52%

Company Profile

Medical Developments International Limited is an Australia-based company that delivers emergency medical solutions dedicated to improving patient outcomes in both domestic and international markets. The Company operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The Company manufactures an inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. The respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.